Filing Details

Accession Number:
0001683168-19-002342
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-24 17:00:14
Reporting Period:
2019-06-16
Accepted Time:
2019-07-24 17:00:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1622879 Medicine Man Technologies Inc. MDCL Services-Management Consulting Services (8742) 465289499
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654539 Justin Dye C/O Medicine Man Technologies, Inc.
4880 Havana Street, Suite 201
Denver CO 90239
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-16 3,500,000 $2.00 5,000,000 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to purchase common stock Acquisiton 2019-06-16 3,500,000 $0.00 3,500,000 $3.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,500,000 2019-06-16 2022-06-16 No 4 P Indirect
Footnotes
  1. On July 16, 2019 and pursuant to the securities purchase agreement (the "Purchase Agreement"), dated June 5, 2019, by and between Medicine Man Technologies, Inc. (the "Company") and Dye Capital Cann Holdings, LLC (the "Investor"), the Investor purchased, in a private placement, 3,500,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock") at a price of $2.00 per share and warrants (the "Warrants") to purchase 3,500,000 shares of Common Stock. The Warrants are for a term of three years and are exercisable at a price of $3.50. The Reporting Person has voting and investment control of the securities owned by the Investor and disclaims beneficial ownership of the securities for purposes of Section 16 except to the extent of the Reporting Person's pecuniary interest therein.